Ryan A Dornbier1, Eric J Kirshenbaum2, Marc H Nelson2, Robert H Blackwell3, Gopal N Gupta2, Ahmer V Farooq2, Christopher M Gonzalez2. 1. Department of Urology, Loyola University Medical Center, 2160 S 1st Avenue, Fahey #54, Rm 239A, Maywood, IL, 60153, USA. Ryan.Dornbier@lumc.edu. 2. Department of Urology, Loyola University Medical Center, 2160 S 1st Avenue, Fahey #54, Rm 239A, Maywood, IL, 60153, USA. 3. Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA.
Abstract
PURPOSE: We sought to determine the socioeconomic and patient factors that influence the utilization of urethroplasty and location of management in the treatment of male urethral stricture disease. METHODS: A retrospective review using the Healthcare Cost and Utilization Project State Inpatient and Ambulatory Surgery and Services Databases for California and Florida was performed. Adult men with a diagnosis of urethral stricture who underwent treatment with urethroplasty or endoscopic dilation/urethrotomy between 2007 and 2011 in California and 2009 and 2014 in Florida were identified by ICD-9 or CPT codes. Patients were categorized based on whether they had a urethroplasty or serial dilations/urethrotomies. Patients were assessed for age, insurance provider, median household income by zip code, Charlson Comorbidity Index, race, prior stricture management, and location of the index procedure. A multivariable logistic regression model was fit to assess factors influencing treatment modality (urethroplasty vs endoscopic management) and location (teaching hospital vs non-teaching hospital). RESULTS: Twenty seven thousand, five hundred and sixty-eight patients were identified that underwent treatment for USD. 25,864 (93.8%) treated via endoscopic approaches and 1704 (6.2%) treated with urethroplasty. Factors favoring utilization of urethroplasty include younger age, lower Charlson Comorbidity score, higher zip code median income quartile, private insurance, prior endoscopic treatment, and management at a teaching hospital. CONCLUSION: Socioeconomic predictors of urethroplasty utilization include higher income status and private insurance. Patient-specific factors influencing urethroplasty were younger age and fewer medical comorbidities. A primary driver of urethroplasty utilization was treatment at a teaching hospital. Older and Hispanic patients were less likely to seek care at these facilities.
PURPOSE: We sought to determine the socioeconomic and patient factors that influence the utilization of urethroplasty and location of management in the treatment of male urethral stricture disease. METHODS: A retrospective review using the Healthcare Cost and Utilization Project State Inpatient and Ambulatory Surgery and Services Databases for California and Florida was performed. Adult men with a diagnosis of urethral stricture who underwent treatment with urethroplasty or endoscopic dilation/urethrotomy between 2007 and 2011 in California and 2009 and 2014 in Florida were identified by ICD-9 or CPT codes. Patients were categorized based on whether they had a urethroplasty or serial dilations/urethrotomies. Patients were assessed for age, insurance provider, median household income by zip code, Charlson Comorbidity Index, race, prior stricture management, and location of the index procedure. A multivariable logistic regression model was fit to assess factors influencing treatment modality (urethroplasty vs endoscopic management) and location (teaching hospital vs non-teaching hospital). RESULTS: Twenty seven thousand, five hundred and sixty-eight patients were identified that underwent treatment for USD. 25,864 (93.8%) treated via endoscopic approaches and 1704 (6.2%) treated with urethroplasty. Factors favoring utilization of urethroplasty include younger age, lower Charlson Comorbidity score, higher zip code median income quartile, private insurance, prior endoscopic treatment, and management at a teaching hospital. CONCLUSION: Socioeconomic predictors of urethroplasty utilization include higher income status and private insurance. Patient-specific factors influencing urethroplasty were younger age and fewer medical comorbidities. A primary driver of urethroplasty utilization was treatment at a teaching hospital. Older and Hispanic patients were less likely to seek care at these facilities.
Authors: Brandon A Mahal; Yu-Wei Chen; Vinayak Muralidhar; Amandeep R Mahal; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Christopher J Sweeney; James B Yu; Felix Y Feng; Simon P Kim; Clair J Beard; Neil E Martin; Quoc-Dien Trinh; Paul L Nguyen Journal: Cancer Date: 2016-07-19 Impact factor: 6.860
Authors: Jerome H Liu; David S Zingmond; Marcia L McGory; Nelson F SooHoo; Susan L Ettner; Robert H Brook; Clifford Y Ko Journal: JAMA Date: 2006-10-25 Impact factor: 56.272
Authors: Sarah D Blaschko; Catherine R Harris; Uwais B Zaid; Tom Gaither; Carissa Chu; Amjad Alwaal; Jack W McAninch; Charles E McCulloch; Benjamin N Breyer Journal: Urology Date: 2015-03-04 Impact factor: 2.649
Authors: Jennifer T Anger; Jill C Buckley; Richard A Santucci; Sean P Elliott; Christopher S Saigal Journal: Urology Date: 2010-12-18 Impact factor: 2.649
Authors: Michael J Consolo; Kirin K Syed; Christopher Robison; Jacob McFadden; David I Shalowitz; Gordon A Brown; David O Sussman; Bradley D Figler Journal: Rev Urol Date: 2016
Authors: Mya Levy; Ronak A Gor; Alex J Vanni; Kristian Stensland; Bradley A Erickson; Jeremy B Myers; Bryan B Voelzke; Thomas G Smith; Benjamin N Breyer; Christopher McClung; Nejd F Alsikafi; Yunhua Fan; Sean P Elliott Journal: Urology Date: 2017-06-01 Impact factor: 2.649
Authors: Eduardo Velasco-Mondragon; Angela Jimenez; Anna G Palladino-Davis; Dawn Davis; Jose A Escamilla-Cejudo Journal: Public Health Rev Date: 2016-12-07